New drug aims to reverse bone marrow scarring in rare blood cancer

NCT ID NCT07394153

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This phase 2 trial tests the drug pacritinib in 30 people with myelofibrosis, a rare bone marrow cancer, who also have low platelet counts. The goal is to see if pacritinib can reduce scarring (fibrosis) in the bone marrow and improve symptoms. Participants take pacritinib pills twice daily for up to two years, with regular check-ups and scans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Pacritinib

What this could lead to

If successful, this could show that pacritinib reduces bone marrow scarring and improves blood cell counts in myelofibrosis patients with low platelets.

What could go wrong

This is a small, early-phase study with only 30 participants and no comparison group. The drug may cause side effects or fail to improve fibrosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELOFIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myelofibrosis primary myelofibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fundación Jimenez Díaz

    RECRUITING

    Madrid, Madrid, 28040, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Clinic de Barcelona

    RECRUITING

    Barcelona, Barcelona, 08036, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Clínico Universitario Valencia

    NOT_YET_RECRUITING

    Valencia, Valencia, 46010, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital General Universitario Gregorio Marañon

    RECRUITING

    Madrid, Madrid, 28007, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital General Universitario Morales Meseguer

    RECRUITING

    Murcia, Murcia, 30008, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital General Universitario de Valencia

    RECRUITING

    Valencia, Valencia, 46014, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario 12 de Octubre

    RECRUITING

    Madrid, Madrid, 28041, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario Doctor Peset

    NOT_YET_RECRUITING

    Valencia, Valencia, 46017, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario Ramon y Cajal

    RECRUITING

    Madrid, Madrid, 28034, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario Vall d´Hebron

    RECRUITING

    Barcelona, Barcelona, 08035, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario de Jerez

    NOT_YET_RECRUITING

    Jerez de la Frontera, Cádiz, 11407, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario de Salamanca

    NOT_YET_RECRUITING

    Salamanca, Salamanca, 37007, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital del Mar Barcelona

    RECRUITING

    Barcelona, Barcelona, 08003, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••